Understanding iDose® TR: A Breakthrough in Glaucoma Treatment

iDose® TR marks a significant breakthrough in the treatment of glaucoma, providing a consistent and reliable option for managing intraocular pressure (IOP). In contrast to traditional eye drops that require daily administration, iDose® TR is a compact, implantable device designed to deliver a controlled dispensation of treatment directly into the eye over an extended period. This groundbreaking approach removes the hassle of daily applications, greatly enhancing patient adherence and overall treatment outcomes.

At Eye Center South, we are proud to offer iDose® TR as part of our comprehensive glaucoma care. The device is implanted during a minimally invasive procedure, designed with your ease in mind. Once in place, it provides a steady release of glaucoma medication, keeping IOP levels consistent and ensuring your visual health. Patients who struggle with the challenges of daily eye drop regimens can benefit greatly from this next-generation treatment.

Visit for more info At Eye Center South